Literature DB >> 9163483

Emergence and dissemination of a highly vancomycin-resistant vanA strain of Enterococcus faecium at a large teaching hospital.

D A Pegues1, C F Pegues, P L Hibberd, D S Ford, D C Hooper.   

Abstract

We prospectively identified patients at the Massachusetts General Hospital from whom vancomycin-resistant enterococci (VRE) were isolated from a clinical specimen from 1 January 1991 through 31 December 1995. VRE strains were available from 139 (82%) of the 169 patients with clinical cases. Of these, 39 (28%) were identical or closely related by pulsed-field gel electrophoresis (i.e., VRE type A strain), including 38 (43%) of 89 VRE strains in 1995. By multivariate analysis, acquisition of the VRE type A strain was associated with receipt of clindamycin (odds ratio [OR] = 10.5), 15 or more days of hospitalization before the first isolation of VRE (OR = 2.9), and residence on one of the general medical floors (OR = 7.8). The VRE type A strain was a vanA strain of Enterococcus faecium and was highly resistant to all antimicrobial agents tested except chloramphenicol. These findings document the rapid dissemination of a highly resistant strain of E. faecium among patients and among other extant VRE strains at the Massachusetts General Hospital in 1995.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9163483      PMCID: PMC229788          DOI: 10.1128/jcm.35.6.1565-1570.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  The VANA glycopeptide resistance protein is related to D-alanyl-D-alanine ligase cell wall biosynthesis enzymes.

Authors:  S Dutka-Malen; C Molinas; M Arthur; P Courvalin
Journal:  Mol Gen Genet       Date:  1990-12

2.  Identification of Enterococcus species isolated from human infections by a conventional test scheme.

Authors:  R R Facklam; M D Collins
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

3.  Species identities of enterococci isolated from clinical specimens.

Authors:  K L Ruoff; L de la Maza; M J Murtagh; J D Spargo; M J Ferraro
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

4.  Controlling vancomycin-resistant enterococci.

Authors:  J M Boyce; L A Mermel; M J Zervos; L B Rice; G Potter-Bynoe; C Giorgio; A A Medeiros
Journal:  Infect Control Hosp Epidemiol       Date:  1995-11       Impact factor: 3.254

5.  CDC definitions for nosocomial infections, 1988.

Authors:  J S Garner; W R Jarvis; T G Emori; T C Horan; J M Hughes
Journal:  Am J Infect Control       Date:  1988-06       Impact factor: 2.918

6.  Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers.

Authors:  L L Livornese; S Dias; C Samel; B Romanowski; S Taylor; P May; P Pitsakis; G Woods; D Kaye; M E Levison
Journal:  Ann Intern Med       Date:  1992-07-15       Impact factor: 25.391

7.  Molecular typing of ampicillin-resistant, non-beta-lactamase-producing Enterococcus faecium isolates from diverse geographic areas.

Authors:  S M Donabedian; J W Chow; J M Boyce; R E McCabe; S M Markowitz; P E Coudron; A Kuritza; C L Pierson; M J Zervos
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

8.  A gene conferring resistance to vancomycin but not teicoplanin in isolates of Enterococcus faecalis and Enterococcus faecium demonstrates homology with vanB, vanA, and vanC genes of enterococci.

Authors:  H S Gold; S Unal; E Cercenado; C Thauvin-Eliopoulos; G M Eliopoulos; C B Wennersten; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

9.  Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states.

Authors:  J W Chow; A Kuritza; D M Shlaes; M Green; D F Sahm; M J Zervos
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

10.  The vanB gene of vancomycin-resistant Enterococcus faecalis V583 is structurally related to genes encoding D-Ala:D-Ala ligases and glycopeptide-resistance proteins VanA and VanC.

Authors:  S Evers; D F Sahm; P Courvalin
Journal:  Gene       Date:  1993-02-14       Impact factor: 3.688

View more
  15 in total

1.  Molecular epidemiology of vancomycin-resistant Enterococcus faecium in a large urban hospital over a 5-year period.

Authors:  W E Bischoff; T M Reynolds; G O Hall; R P Wenzel; M B Edmond
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  High prevalence of vancomycin-resistant enterococci in Swedish sewage.

Authors:  Aina Iversen; Inger Kühn; Anders Franklin; Roland Möllby
Journal:  Appl Environ Microbiol       Date:  2002-06       Impact factor: 4.792

Review 3.  Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci.

Authors:  Stephan Harbarth; Sara Cosgrove; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

4.  Isolation and characterization of glycopeptide-resistant enterococci from hospitalized patients over a 30-month period.

Authors:  R R Nelson; K F McGregor; A R Brown; S G Amyes; H Young
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

5.  An Update on the Emergence of Glycopeptide Resistance in Enterococci.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

6.  Epidemiology of glycopeptide-resistant enterococci colonizing high-risk patients in hospitals in Johannesburg, Republic of South Africa.

Authors:  A von Gottberg; W van Nierop; A Dusé; M Kassel; K McCarthy; A Brink; M Meyers; R Smego; H Koornhof
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

7.  Detection of enterococcal surface protein gene (esp) and amplified fragment length polymorphism typing of glycopeptide-resistant Enterococcus faecium during its emergence in a Greek intensive care unit.

Authors:  C Routsi; E Platsouka; R J L Willems; M J M Bonten; O Paniara; G Saroglou; C Roussos
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

8.  Molecular diversity and evolutionary relationships of Tn1546-like elements in enterococci from humans and animals.

Authors:  R J Willems; J Top; N van den Braak; A van Belkum; D J Mevius; G Hendriks; M van Santen-Verheuvel; J D van Embden
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

9.  Isolation of glycopeptide-resistant enterococci from chicken in Japan.

Authors:  H Yoshimura; M Ishimaru; Y S Endoh; M Suginaka; S Yamatani
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

10.  Comparison of glycopeptide-resistant Enterococcus faecium isolates and glycopeptide resistance genes of human and animal origins.

Authors:  P R Descheemaeker; S Chapelle; L A Devriese; P Butaye; P Vandamme; H Goossens
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.